Hjem › Seglcelle-anæmi › Maryland
Seglcelle-anæmi kliniske forsøg i Maryland
17 studier for Seglcelle-anæmi søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 70 · Alle køn · Opdateret 2. okt. 2026 · NCT03937817Blood Sampling for Research Related to Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 100 · Alle køn · Opdateret 29. sep. 2026 · NCT00542230Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
- National Institutes of Health Clinical Center, Bethesda
RekruttererTidlig fase 1
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06313398A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- The Johns Hopkins University School of Medicine, Baltimore
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
Alder 18 til 120 · Alle køn · Opdateret 18. sep. 2026 · NCT05170412Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 17. sep. 2026 · NCT05904093Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
Alder 2 til 99 · Alle køn · Opdateret 11. sep. 2026 · NCT06944067SCD Stem Cell Mobilization and Apheresis Using Motixafortide
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 4 til 65 · Alle køn · Opdateret 4. sep. 2026 · NCT07599176Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 90 · Alle køn · Opdateret 24. aug. 2026 · NCT07566494A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0064, Baltimore
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Johns Hopkins University Hemophilia Treatment Center, Baltimore
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Maryland, Baltimore
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Center for Cancer and Blood Disorders, Bethesda
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore
RekruttererFase 3
Alder 10 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT06975865Cooperative Assessment of Late Effects for SCD Curative Therapies
- Johns Hopkins Hospital, Baltimore
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
Alder 4 til 65 · Alle køn · Opdateret 27. jul. 2026 · NCT05153967Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
- University of Maryland Medical Systems, Baltimore
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 24. dec. 2025 · NCT06184126Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.